 | Pfizer–BioNTech COVID-19 vaccine (redirect from Comirnaty) The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company... 236 KB (19,394 words) - 05:58, 20 April 2024 |
is the first RNAi drug to receive regulatory approval. The second is Comirnaty, the COVID-19 mRNA vaccine developed by Pfizer/BioNTech that has received... 19 KB (1,222 words) - 09:34, 28 April 2024 |
name Comirnaty, is an mRNA vaccine produced by the German company BioNTech and the American company Pfizer. In Hong Kong, Macau, and Taiwan, Comirnaty is... 318 KB (19,351 words) - 20:00, 21 April 2024 |
Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2 (later branded as Comirnaty). This approval enabled the start of the UK's COVID-19 vaccination programme... 24 KB (2,284 words) - 11:01, 6 March 2024 |
 | Kingdom, 138,000 people had received the Pfizer-BioNTech COVID‑19 vaccine Comirnaty by 16 December, during the first week of the UK vaccination programme... 122 KB (11,028 words) - 02:32, 27 January 2024 |
vaccines, of which the first authorized were COVID-19 vaccines (such as Comirnaty and Spikevax). mRNA is produced by synthesising a ribonucleic acid (RNA)... 24 KB (2,503 words) - 11:29, 22 February 2024 |
 | Pharma Proprietary medications Pfizer Generic Viagra, Comirnaty (tozinameran, co-op with BioNTech) GlaxoSmithKline Amoxil (amoxicillin), Ventolin (salbutamol)... 33 KB (3,259 words) - 10:15, 7 April 2024 |
 | Erstens stimmt es nicht, dass die Zusatzstoffe unerlaubt sind. Denn Comirnaty ist zugelassen und damit sind auch alle darin enthaltenen Hilfsstoffe... 8 KB (782 words) - 12:58, 24 January 2024 |
 | do not jeopardize the quality and integrity of the data from the main Comirnaty trial and have no impact on the benefit-risk assessment or on the conclusions... 170 KB (14,804 words) - 20:40, 28 April 2024 |
$2 billion NxStage acquisition". Modern Healthcare. "Package Insert - Comirnaty". U.S. Food and Drug Administration. December 2021. Retrieved 2022-05-24... 19 KB (1,639 words) - 08:00, 18 April 2024 |
 | Tozinameran – COVID-19 vaccine from Pfizer BioNTech, sold under the brand name Comirnaty Uğur Şahin – German oncologist and immunologist (born 1965), co-founder... 38 KB (4,177 words) - 12:44, 18 April 2024 |
for Pfizer and BioNTech's COVID-19 vaccine, Comirnaty, and its nonproprietary name, tozinameran. Comirnaty was the first COVID-19 vaccine brand name approved... 10 KB (885 words) - 15:16, 23 April 2024 |
 | Today. 2020;S1359-6446(20)30509-2. doi:10.1016/j.drudis.2020.11.025 "Comirnaty and Pfizer-BioNTech COVID-19 Vaccine". FDA. January 3, 2022. Archived... 116 KB (11,587 words) - 06:13, 27 April 2024 |
 | Hospitalization effectiveness Mortality effectiveness Spikevax 91.45% 78% 93.46% Comirnaty 80.34% 84.26% 89.83% Sputnik V 78.75% 81.38% 87.7% Covishield 80.79% 80... 154 KB (13,880 words) - 13:52, 20 April 2024 |
December 2020. "EMA recommends standard marketing authorizations for Comirnaty and Spikevax COVID-19 vaccines". European Medicines Agency. 16 September... 192 KB (22,021 words) - 19:29, 15 April 2024 |
 | cooperation with the American company Pfizer sold under the brand name Comirnaty. On 24 August 2020 WHO stated that COVAX had nine CEPI-supported vaccine... 57 KB (4,065 words) - 11:56, 24 February 2024 |
 | recommendations for the rollout of the vaccine, recommending that the Pfizer Comirnaty vaccine be used for people aged under 60 years if the person has not already... 212 KB (16,954 words) - 18:04, 29 April 2024 |
 | vaccine from BioNTech/Pfizer, also known as BNT162b2, tozinameran or Comirnaty, all U's have been substituted with N1-methylpseudouridine, a nucleoside... 24 KB (2,806 words) - 06:49, 1 April 2024 |
 | Medicine), showed that a third dose of the Comirnaty vaccine given to those who received two doses of either Comirnaty or CoronaVac provided protective levels... 120 KB (11,030 words) - 21:48, 14 April 2024 |
from Pfizer". ICU Medical. Retrieved 28 April 2017. "Package Insert - Comirnaty". U.S. Food and Drug Administration. December 2021. Retrieved 2022-05-24... 17 KB (1,388 words) - 23:45, 26 October 2023 |
 | Venezuela. On 26 August 2021, Pfizer Inc. and BioNTech, the developers of the COMIRNATY vaccine against COVID-19, announced a partnership with Eurofarma to manufacture... 5 KB (346 words) - 19:31, 28 March 2023 |
 | currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed by University of Oxford and AstraZeneca (Vaxzevria)... 99 KB (8,236 words) - 05:40, 15 April 2024 |
injection" (PDF). Regulation 174. MHRA. 15 December 2020. Assessment report, Comirnaty, Common name: COVID-19 mRNA vaccine (nucleoside-modified); Procedure No... 2 KB (205 words) - 21:16, 8 February 2024 |
provisionally approved the two-dose Pfizer–BioNTech COVID-19 vaccine, named COMIRNATY, for use within Australia. The provisional approval only recommends the... 23 KB (1,797 words) - 14:29, 7 January 2024 |
 | Johnson's Janssen, Pfizer-BioNTech's Comirnaty, and Oxford-AstraZeneca; administering both Janssen and Comirnaty, but the Oxford-AstraZeneca vaccine was... 252 KB (12,390 words) - 19:51, 24 March 2024 |
 | Advisory Group on Immunisation (ATAGI) recommended that the Pfizer vaccine (Comirnaty) be preferred over the AstraZeneca vaccine in people under the age of... 178 KB (12,119 words) - 03:08, 8 March 2024 |
 | (CHMP) (19 February 2021). "European public assessment report (EPAR) – Comirnaty, INN-COVID-19 mRNA Vaccine (nucleoside-modified)" (PDF). European Medicines... 43 KB (3,701 words) - 10:53, 29 April 2024 |
 | 10 January 2022. "EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines". European Medicines Agency (Press release)... 165 KB (13,017 words) - 17:59, 27 April 2024 |
 | president Donald Trump to emphasize that the pandemic started in China. Comirnaty The commercial name for the FDA approved COVID-19 vaccine from Pfizer... 8 KB (852 words) - 09:41, 11 January 2024 |
 | BNT162b2 (the Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty). Türeci credits the rapid success of the project in part to international... 41 KB (3,474 words) - 00:55, 27 April 2024 |